###begin article-title 0
Mitochondrial abnormalities in spinal and bulbar muscular atrophy
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by polyglutamine expansion mutation in the androgen receptor (AR). We investigated whether the mutant protein alters mitochondrial function. We found that constitutive and doxycycline-induced expression of the mutant AR in MN-1 and PC12 cells, respectively, are associated with depolarization of the mitochondrial membrane. This was mitigated by cyclosporine A, which inhibits opening of the mitochondrial permeability transition pore. We also found that the expression of the mutant protein in the presence of ligand results in an elevated level of reactive oxygen species, which is blocked by the treatment with the antioxidants co-enzyme Q10 and idebenone. The mutant protein in MN-1 cells also resulted in increased Bax, caspase 9 and caspase 3. We assessed the effects of mutant AR on the transcription of mitochondrial proteins and found altered expression of the peroxisome proliferator-activated receptor gamma coactivator 1 and the mitochondrial specific antioxidant superoxide dismutase-2 in affected tissues of SBMA knock-in mice. In addition, we found that the AR associates with mitochondria in cultured cells. This study thus provides evidence for mitochondrial dysfunction in SBMA cell and animal models, either through indirect effects on the transcription of nuclear-encoded mitochondrial genes or through direct effects of the mutant protein on mitochondria or both. These findings indicate possible benefit from mitochondrial therapy for SBMA.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C1">1</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C2">2</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C1">1</xref>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C3">3</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C4">4</xref>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C4">4</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C5">5</xref>
Spinal and bulbar muscular atrophy (SBMA) results from the expansion of a polyglutamine tract in the androgen receptor (AR) (1). SBMA is one of at least nine diseases with polyglutamine expansion, including Huntington's disease (HD), dentatorubral-pallidoluysian atrophy and six spinocerebellar ataxias (2). SBMA is X-linked and fully affects only males (1). The polyglutamine expansion in the AR results in selective degeneration of motor neurons in the brainstem and spinal cord (3,4). The clinical characteristics of SBMA include muscle cramps, slowly progressive extremity weakness, muscle atrophy, fasciculations, dysphagia and signs of androgen insensitivity, such as gynecomastia and reduced fertility (4,5).
###end p 4
###begin p 5
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C6">6</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C6">6</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C7">7</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C8">8</xref>
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C9">9</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C10">10</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C11">11</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C15">15</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C12">12</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C14">14</xref>
###xml 765 780 <span type="species:ncbi:10090">transgenic mice</span>
The AR is a member of the nuclear receptor family and a ligand-activated transcription factor (6). In its inactive state, the AR is cytoplasmic and sequestered by heat shock proteins. On ligand binding, it dissociates from the complex of heat shock proteins and translocates to the nucleus where it binds to specific DNA sequences and activates transcription (6). The polyglutamine expansion in the AR likely confers a toxic gain and also a partial loss of AR function (7,8). Aberrant interactions of the mutant AR with other proteins, including transcriptional co-activators, result in transcriptional dysregulation and neuronal toxicity (9,10). There is considerable evidence supporting ligand-dependent toxicity (11-15). For example, reducing androgen levels in transgenic mice rescues the motor impairment and increases survival (12,14). These studies point to altered transcriptional regulation as a disease mechanism, but they do not preclude the possibility of toxicity in the cytoplasmic compartment. The specific mechanism of SBMA remains unclear, and there is currently no effective treatment.
###end p 5
###begin p 6
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C16">16</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C21">21</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C22">22</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C24">24</xref>
###xml 529 531 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C23">23</xref>
###xml 532 534 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C26">26</xref>
###xml 667 669 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C27">27</xref>
###xml 670 672 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C28">28</xref>
###xml 910 912 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C29">29</xref>
###xml 913 915 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C30">30</xref>
Mitochondrial dysfunction has been implicated in various neurodegenerative diseases, including Huntington's disease (HD), amyotrophic lateral sclerosis (ALS) and Friedreich's ataxia (16-21). It is also known that transcriptional dysregulation in the nucleus can affect mitochondrial turnover and oxidative phosphorylation (22-24). Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) and its homolog, PGC-1beta, are nuclear transcriptional co-activators and important regulators of energy metabolism (23-26). Recent studies in HD show altered PGC-1alpha to be a likely link between transcriptional dysregulation and mitochondrial defects (27,28). Currently, little is known about mitochondrial involvement in SBMA. Previous studies in cell models suggest alterations in mitochondrial distribution and sequestration of nuclear-encoded mitochondrial proteins in mutant AR aggregates (29,30).
###end p 6
###begin p 7
###xml 877 885 874 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 842 847 <span type="species:ncbi:10090">mouse</span>
In this study, we investigated whether mutant AR alters mitochondrial function in models of SBMA. We found that the expression of mutant AR in motor neuron-derived (MN-1) cells and with doxycycline induction in pheochromacytoma-derived (PC12) cells is associated with mitochondrial membrane depolarization and increased reactive oxygen species (ROS). Cyclosporine A (CsA) mitigates the membrane depolarization, and the increase in ROS levels is blocked by the antioxidants co-enzyme Q10 (CoQ10) and idebenone. We also found that the mutant AR increases Bax protein levels, and activates caspases 9 and 3. The activation of caspases 9 and 3 is likely mediated by the mitochondrial transition pore. Moreover, we observed decreased levels of PGC-1beta and mitochondrial superoxide dismutase (SOD2) in MN-1 cells and in the tissues of a knock-in mouse model of SBMA. We also found in vitro evidence for association of AR with mitochondria. At the ultrastructural level, this association is greater with the AR containing the expanded repeat. Taken together, our results implicate mitochondrial abnormalities and redox imbalance in SBMA. This study provides evidence that mitochondrial modulators and antioxidants may have therapeutic value in SBMA.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
Mutant AR activates the mitochondrial caspase pathway
###end title 9
###begin p 10
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C31">31</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C34">34</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C35">35</xref>
###xml 501 502 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 519 520 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
###xml 656 658 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C36">36</xref>
###xml 928 929 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 946 947 938 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
###xml 1265 1266 1257 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
###xml 1314 1316 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C31">31</xref>
###xml 1531 1532 1523 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
###xml 1868 1869 1858 1859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2015 2016 2001 2002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2033 2034 2017 2018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
Previous studies have shown that the expression of mutant AR results in the activation of caspase 3 in motor neuron-like cells (MN-1) (31-34). To investigate whether caspase 9, a mediator of the mitochondrial caspase pathway and activator of caspase 3, is also involved in SBMA pathogenesis, we used MN-1 cells that stably express either normal (AR-24Q) or mutant AR (AR-65Q) (35). We found that the ligand exposure increases caspase 9 activity by 50 +/- 12% in AR-65Q cells compared to AR-24Q cells (P </= 0.05) (Fig. 1A). Opening of the mitochondrial transition pore (MTP) is involved in the activation of caspase 9, and CsA inhibits opening of the MTP (36). Therefore, we tested whether the caspase 9 activation observed in MN-1 cells expressing mutant AR could be decreased by CsA. We found that the ligand-induced increase in caspase 9 activity in AR-65Q cells is decreased by 32 +/- 8% by treatment of the cells with CsA (P </= 0.05) (Fig. 1A). As a positive control for caspase 9 inhibition, we used the specific caspase 9 inhibitor Ac-LEHD-CHO. Next, we asked whether caspase 9 is upstream of caspase 3 in MN-1 cells expressing mutant AR. Although in this cell model of SBMA caspase-3 activation is not ligand-dependent, it is polyglutamine-dependent (Fig. 1B), which is consistent with a previous report (31). Treatment of cells with another caspase 9 inhibitor z-LEHD-FMK blocked the increase in caspase 3 activity by 47%, indicating that the activation of caspase 3 is at least in part due to caspase 9 activation (Fig. 1B). To further test the hypothesis that the mitochondrial caspase pathway is involved in SBMA, we examined whether inhibiting the MTP abrogates caspase 3 activation using a fluorescent-based assay (MitoCasp). As a positive control for this assay, we used staurosporine, an apoptotic inducer (). We found that the increase of 29 +/- 4% (P </= 0.01) in caspase 3 activity observed in the AR-65Q cells relative to the AR-24Q cells was blocked by treating the cells with CsA (39 +/- 7%; P </= 0.01) (Fig. 1C).
###end p 10
###begin p 11
###xml 56 57 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 354 355 354 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 688 689 688 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1149 1150 1149 1150 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1314 1315 1314 1315 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1584 1585 1584 1585 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1933 1934 1933 1934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Mutant AR activates the mitochondrial caspase pathway. (A) MN-1 cells expressing the normal and mutant AR were exposed to vehicle alone or androgen ligand (R1881), with and without caspase 9 inhibitor (Ac-LEHD) or CsA. The AR-65Q cells had an increase in caspase 9 activity in the presence of R1881. CsA and the caspase 9 inhibitor block this increase. (B) Caspase 3 activity was measured with a fluorometric assay in the AR-24Q and AR-65Q MN-1 cells. These cells were treated with vehicle alone, caspase 9 inhibitor (z-LEHD-FMK) or pan-caspase inhibitor (z-VAD). AR-65Q cells showed a ligand-independent increase in caspase 3 activity. This increase is partially blocked by z-LEHD-FMK. (C) We measured caspase 3 activity with another fluorometric assay in MN-1 cells expressing AR-24Q and AR-65Q cells. The cells were treated with either vehicle or CsA. There was an increase in caspase 3 activity in cells expressing the mutant AR. This increase is ligand-independent and partially blocked with CsA. The caspase activities are indicated as percent activity relative to untreated AR-24Q (assigned as 100%) and normalized to total protein content. (D) Immunoblotting of MN-1 total cellular lysates shows increased Bax relative to tubulin in AR-65Q cells. The first lane shows vehicle-treated parental MN-1 cells. (E) Immunoblotting of MN-1 cells for cytochrome C in mitochondrial and cytosolic fractions show no change in cytochrome C release in AR-65Q cells relative to parental MN-1 or AR-24Q cells. The last lane shows HeLa cells treated with staurosporine as a positive control. (F) Immunoblotting of MN-1 total cell lysates for phosphorylated Bad and total Bad. Quantitation showed no change in the ratio of phosphorylated and total Bad in AR-65Q cells relative to AR-24Q cells. The graphs (A-C) show data representative of three experiments each done in triplicate with the error bars indicating standard error of mean (SEM); *P </= 0.05.
###end p 11
###begin p 12
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C37">37</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C39">39</xref>
###xml 427 428 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 445 446 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
###xml 509 510 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
###xml 1010 1012 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C39">39</xref>
###xml 1013 1015 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C41">41</xref>
###xml 1183 1184 1179 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F1">1</xref>
Alterations in the pro-apoptotic proteins, Bax and Bad and subcellular localization of cytochrome C are associated with the caspase 9/caspase 3 cascade (37-39). Therefore, we tested whether the expression of these markers of mitochondria-dependent apoptosis is altered in MN-1 cells expressing mutant AR. We found that the expression of expanded polyglutamine AR in MN-1 cells increased the levels of Bax protein by 15 +/- 3% (P </= 0.05) (Fig. 1D). We did not detect any change in cytochrome C release (Fig. 1E). As control for Bax levels and release of cytochrome C, we used lysates of HeLa cells treated with staurosporine (data not shown). It has previously been shown that the pro-apoptotic protein Bad when phosphorylated remains inactive and sequestered in the cytoplasm by the transcription factor, 14-3-3. Upon the activation of the calcineurin pathway, Bad is dephosphorylated and translocates to the mitochondria where it inactivates the anti-apoptotic protein, Bcl-xL and then activates caspase 9 (39-41). To test whether Bad is activated in MN-1 cells expressing mutant AR, we did immunoblotting in MN-1 total cell extracts for phospho-Bad (Ser 136) and total Bad (Fig. 1F). We found no difference in phosphorylated Bad in AR-65Q cells compared to AR-24Q cells. Taken together, these results indicate that mutant AR increases Bax levels and activates the mitochondrial caspase pathway independently of cytochrome C release and dephosphorylation of Bad.
###end p 12
###begin title 13
Mitochondrial mass and number are reduced in cells expressing mutant AR
###end title 13
###begin p 14
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
###xml 476 477 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 502 503 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 693 694 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
###xml 913 914 905 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
We next sought to determine whether cells expressing mutant AR have mitochondrial abnormalities. We tested this in both stable MN-1 cells and inducible PC12 cells expressing either normal or mutant AR (Fig. 2A and B). We used a mitochondria specific fluorescent dye, MitoTracker Green FM, to examine mitochondrial mass by flow cytometry. This dye localizes to mitochondria independent of the functional state. We found that the fluorescent signal was decreased by 43 +/- 11% (P </= 0.01) and 6 +/- 1% (P </= 0.0001) relative to normal cells in mutant MN-1 cells and PC12 cells, respectively. There was no further decrease in percent mitogreen positive cells upon the addition of ligands (Fig. 2A-B). As a positive control, we used antimycin A, an inhibitor of complex III of the electron transport chain, and we found that it decreases mitochondrial mass by greater than 60% in both AR-24Q and AR-65Q cells (Fig. 2A).
###end p 14
###begin p 15
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 632 633 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 645 646 641 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 651 652 647 648 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 939 940 935 936 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1044 1045 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Reduced mitochondrial mass and number in cells expressing mutant AR. (A) AR-24Q and AR-65Q MN-1 cells and (B) differentiated AR-10Q and AR-112Q PC12 cells left uninduced or induced to express AR were treated with vehicle or the mitochondrial toxin, antimycin A for 48 h. The cells were then stained with a fluorescent marker and mitochondrial mass was analyzed by flow cytometry. AR-65Q (A) and AR-112Q cells (B) have ligand-independent decrease in mitochondrial mass. The data in both panels were normalized to the respective vehicle treated normal cells (set as 100%). Shown are the mean +/- standard error of three experiments; *P </= 0.05. (C and D) Representative high magnification (10 000x) electron micrographs of AR-24Q (C) and AR-65Q MN-1 (D) cells exposed to vehicle for 24 h. The micrographs show more mitochondria (arrows in B) in AR-24Q compared to AR-65Q cells. The AR-65Q cells have vesiculated cristae (arrowheads in D). (E) The total number of mitochondria was counted in 10-12 cells per sample. The error bars indicate SEM; *P </= 0.05.
###end p 15
###begin p 16
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
###xml 530 531 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 632 633 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F2">2</xref>
We asked whether the expression of mutant AR in MN-1 cells affects mitochondrial morphology and number. We tested this in MN-1 cells expressing AR-24Q (Fig. 2C) and AR-65Q (Fig. 2D) by electron microscopy. We found that the morphology of mitochondria in mutant MN-1 cells is altered, as the mitochondria in the AR-65Q cells have vesiculated cristae (Fig. 2D; arrowheads), whereas there are numerous electron dense branched cristae in mitochondria of the AR-24Q cells (Fig. 2D; arrows). Quantitative assessment showed a 61 +/- 6% (P </= 0.01) decrease in total mitochondrial number in AR-65Q cells compared to the AR-24Q cells (Fig. 2E). This decrease was not exacerbated by exposure of the cells to ligand. Together these data indicate a polyglutamine-dependent decrease in mitochondrial mass and number.
###end p 16
###begin title 17
Cells expressing mutant AR have decreased mitochondrial membrane potential
###end title 17
###begin p 18
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C42">42</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C43">43</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C44">44</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C45">45</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C45">45</xref>
###xml 733 734 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 884 885 880 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F3">3</xref>
###xml 905 906 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 971 972 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F3">3</xref>
###xml 1075 1076 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1115 1116 1101 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1262 1263 1246 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F3">3</xref>
Abnormalities in mitochondrial membrane potential (MtMP) are associated with mitochondrial dysfunction through alteration in bioenergetic function (42,43). To investigate whether the activation of the mitochondrial caspase pathway and reduced number of mitochondria observed in the AR-65Q cells are associated with mitochondrial dysfunction, we examined the MtMP in MN-1 cells. We used the ratiometric cationic dye JC1, which localizes to the mitochondria, and emits a fluorescent signal that varies with the membrane potential (44,45). To capture the heterogeneity of responses across the cell population, we assessed the membrane potential using a fluorescent-activated cell sorter (FACS) (45). We observed an increase (15 +/- 5%; P </= 0.05) in mitochondrial membrane depolarization (increased ratio of green to red fluorescence) in the AR-65Q cells compared to AR-24Q cells (Fig. 3A) and a 38 +/- 3% (P </= 0.05) increase in the PC12 cells expressing mutant AR (Fig. 3B). This depolarization was further increased in the presence of the ligand in mutant MN-1 (32 +/- 5%; P </= 0.05) and PC12 cells (46 +/- 15%; P </= 0.01). CsA reversed the ligand-dependent depolarization in both MN-1 and PC12 cells, suggesting involvement of the MTP in this process (Fig. 3A and B). Assessment of the MtMP using TMRM, another mitochondria specific potentiometric dye, yielded results consistent with the FACS analysis using JC1 (data not shown). Together, these results suggest that mutant AR causes membrane changes indicative of mitochondrial dysfunction in an expanded polyglutamine-dependent and ligand-dependent manner.
###end p 18
###begin p 19
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Mutant AR is associated with decreased MtMP. (A) AR-24Q and AR-65Q MN-1 cells and (B) differentiated AR-10Q and AR-112Q PC12 cells induced to express AR were exposed to vehicle alone, and ligand (R1881 or DHT) or CsA or both. Using flow cytometry, MtMP was measured with a fluorescent indicator of MtMP and expressed relative to the vehicle-treated cells. Depolarization was significantly greater in both AR-65Q MN-1 (A) and AR-112Q PC12 cells (B) compared to the respective normal AR expressing cells. The depolarization is significantly increased by the addition of ligand to the mutant cells. In addition, CsA blocks this depolarization. The histograms represent five (A) and two (B) independent experiments each done in triplicate, with the error bars showing the SEM; *P </= 0.05.
###end p 19
###begin title 20
Increased reactive oxygen species in SBMA cell models
###end title 20
###begin p 21
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C46">46</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C47">47</xref>
###xml 312 313 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 330 331 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F4">4</xref>
###xml 461 462 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 488 489 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 551 552 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 624 625 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F4">4</xref>
###xml 711 712 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 739 740 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 771 772 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F4">4</xref>
One of the downstream effects of mitochondrial dysfunction is oxidative stress through the generation of ROS (46,47). We assessed ROS using dihydrorhodamine 123 (DHR123), an oxidation-sensitive fluorometric dye that localizes to mitochondria. Exposure of AR-65Q cells to R1881 increased ROS levels by 20 +/- 2% (P </= 0.01) (Fig. 4A). Treatment of these cells with the antioxidants co-enzyme Q10 (CoQ10) and idebenone blocked this increase in ROS by 13 +/- 2% (P </= 0.01) and 18 +/- 1% (P </= 0.01), respectively. Similarly we observed a 57 +/- 13% (P </= 0.01) increase in ROS in mutant PC12 cells exposed to ligand (Fig. 4B). CoQ10 and idebenone blocked this increase in the mutant PC12 cells by 23 +/- 13% (P </= 0.05) and 30 +/- 17% (P </= 0.05), respectively (Fig. 4B).
###end p 21
###begin p 22
###xml 25 26 25 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Mutant AR increases ROS (A) AR-24Q and AR-65Q MN-1 cells and (B) differentiated AR-10Q and AR-112Q PC12 cells induced to express AR were exposed to vehicle alone, ligand (R1881 or DHT) and CoQ10 or idebenone. ROS levels were measured with a fluorometric assay and are indicated relative to vehicle-treated AR-24Q cells (A) or vehicle-treated cells induced to express AR-10Q (B) (assigned as 100%). In both mutant MN-1 (A) and PC12 (B) cells, ROS levels increased with ligand and co-enzyme Q10 and idebenone blocked this increase. The graph shows representative results of one of the three independent experiments in (A), and the average of three experiments in (B), which were each done in triplicate. The error bars indicate the SEM; *P </= 0.05.
###end p 22
###begin title 23
Mutant AR alters the expression of genes important for mitochondrial function
###end title 23
###begin p 24
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C26">26</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C48">48</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C49">49</xref>
###xml 338 339 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 446 447 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 756 757 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 1184 1185 1159 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1294 1295 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 1728 1729 1695 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1746 1747 1711 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 2019 2020 1984 1985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 1953 1960 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
We next investigated whether mitochondrial dysfunction is associated with altered expression of genes related to mitochondrial function in AR-24Q and AR-65Q MN-1 cells when exposed to ligand (Fig. 5A). PGC-1 is a key regulator of mitochondrial biogenesis and function (26,48,49). We found that PGC-1beta mRNA was decreased by 48 +/- 10% (P </= 0.001) in the presence of ligand in cells expressing AR-65Q relative to cells expressing AR-24Q (Fig. 5A). Peroxisome proliferator-activated receptor-gamma (PPARgamma) and mitochondrial transcription factor A (Tfam) are two nuclear-encoded genes regulated by PGC-1. The expression levels of PPARgamma and Tfam were downregulated by 40 +/- 10 and 59 +/- 7%, respectively, in the ligand-exposed AR-65Q cells (Fig. 5A). Tfam in turn regulates transcription of genes encoded by mitochondrial DNA, including subunits of complexes of the electron transport chain. We examined mRNA levels for the mitochondrial proteins NADH dehydrogenase 1 and 5 (ND1 and ND5), which are subunits of complex I, and cytochrome c oxidase I, II and III (COX I, II and III), which are subunits of complex IV. ND1 mRNA levels were significantly decreased (64 +/- 13%; P </= 0.05) in AR-65Q cells exposed to ligand, while expression of ND5, COX I, II and III was unaltered (Fig. 5A). To further assess whether the transcription of genes involved in redox balance is affected in the ligand-exposed AR-65Q cells, we examined the transcript levels of antioxidant genes. We quantified the mRNA levels of SOD2 and other cellular antioxidants [SOD1, catalase and glutathione peroxidase (Gpx1)] and found that transcript levels of SOD1, SOD2 and catalase were reduced by 42 +/- 6, 58 +/- 17 and 46 +/- 7%, respectively (P </= 0.05) (Fig. 5A). Gpx1 mRNA levels were unchanged. In addition, we found that ligand treatment did not alter transcript levels of NF-E2-related factor-2 (Nrf2), a regulator of antioxidant genes, and its targets, NAD(P)H:quinine oxidoreductase 1 (NQO1) and heme-oxygenase 1 (HO-1) (Fig. 5A). We verified that the decrease in SOD2 transcription translates into protein changes by immunocytochemistry (). We found a decrease in SOD2 staining (FITC-labeled) in ligand-treated mutant MN-1 cells. As a mitochondrial marker, we used Hsp60, and we found that there was a decrease, consistent with reduced mitochondrial number or mass ().
###end p 24
###begin p 25
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 128 129 128 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 134 135 134 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 151 152 151 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 157 158 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 178 179 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 783 784 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 797 798 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 812 813 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 832 833 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 575 580 <span type="species:ncbi:10090">mouse</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
Mutant AR alters expression of genes important for mitochondrial function. Total RNA from MN-1 cells (A), and hind limb muscle (B and C), spinal cord (D and E) and testis (F and G) of mice expressing AR-21Q, and AR-113Q was analyzed by quantitative RT-PCR as described in Materials and Methods. All transcript levels were normalized to the loading control, S18. (A) Gene expression of R1881-exposed MN-1 cells is shown relative to the respective vehicle treated controls (assigned as 1). (B-G) Transcript levels of pre-manifesting (B, D, F) and manifesting (C, E, G) AR-113Q mouse muscle (B, C), spinal cord (D, E) and testis (F, G) are shown relative to transcript levels in AR-21Q mice (assigned as 1). All experiments were done in triplicate, with the error bars indicating SEM; *P </= 0.05, **P </= 0.01, ***P </= 0.001 and ****P </= 0.0001.
###end p 25
###begin p 26
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
We then examined the expression of these genes in muscles, testis and spinal cord from a knock-in mouse model of SBMA (Fig. 5B-G). We analyzed mRNA levels in pre-manifesting 1 month old (Fig. 5B, D and F) and weakness-manifesting 5 month old (Fig. 5C, E and G) mutant AR mice (AR-113Q), and compared the results to mice expressing non-pathological repeat length AR (normal AR mice; AR-21Q).
###end p 26
###begin p 27
###xml 91 92 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 103 105 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 119 120 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 131 133 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 150 151 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 188 189 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 211 212 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 232 233 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 344 345 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 477 478 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 489 492 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 499 500 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 515 516 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 527 529 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 536 537 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 555 556 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 567 569 537 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 576 577 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 683 684 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 707 708 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 734 735 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 746 748 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 804 805 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
Notably, we found that in pre-manifesting mice, PGC-1beta mRNA was decreased by 68 +/- 3% (P </= 1 x 10-6), 36 +/- 2% (P </= 1 x 10-6) and 17 +/- 3% (P </= 0.01) in hind limb muscle (Fig. 5B), spinal cord (Fig. 5D) and testis (Fig. 5F), respectively. The levels of PGC-1beta mRNA remained reduced in muscle and testis of 5 month old mice (Fig. 5C and G). Moreover, we found that in 1 month old mutant mice, SOD2 mRNA was reduced in muscle, spinal cord and testis by 42 +/- 2% (P </= 1 x 10-10; Fig. 5B), 11 +/- 1% (P </= 1 x 10-8; Fig. 5D) and 44 +/- 1% (P </= 1 x 10-8; Fig. 5F), respectively. In 5 month old mutant mice, the SOD2 transcript levels remained decreased by 20 +/- 2% (P </= 0.05), 19 +/- 3% (P </= 0.05) and 50 +/- 3% (P </= 1 x 10-5) in muscle, spinal cord and testis, respectively (Figs 5C, E and G). We examined SOD2 protein levels in immunoblots of muscle and spinal cord tissue lysates of pre-manifesting (1 month) and manifesting (3 month) mice. We found decreased levels of SOD2 in both muscle () and spinal cord of 3 month old mice ().
###end p 27
###begin p 28
###xml 91 92 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 127 128 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 267 268 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 327 328 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 428 429 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 547 548 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 579 580 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 798 799 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F5">5</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
In addition, we found that the mRNA levels of Tfam were reduced in spinal cord (31 +/- 3%; P </= 0.001) and testis (20 +/- 2%; P </= 0.05) of mice at the pre-manifesting stage. ND1 and ND5 mRNA levels were increased in all three tissues in the 1 month old mice (Fig. 5B, D and F), but decreased as the disease progressed (Fig. 5C, E and G). The expression of Nrf2 and NQO1 was increased in the tissues of 1 month old mice (Fig. 5B, D and F). There was little or no change in PGC-1alpha, COX I, COX II, COX III, SOD1, Gpx1 and HO-1 in muscle (Fig. 5B and C) and spinal cord (Fig. 5D and E) of 1 and 5 month old mutant mice. In the testis of 5 month old mutant mice, all the analyzed genes had significant reduction in mRNA levels, with the exception of NQO1 and catalase, which were unaltered (Fig. 5G).
###end p 28
###begin title 29
Altered subcellular distribution of androgen receptor
###end title 29
###begin p 30
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
We hypothesized that the mitochondrial abnormalities found in cells expressing mutant AR may be due in part to direct association of mutant AR with mitochondria. To test this, we performed subcellular fractionation of MN-1 (Fig. 6A-C) and PC12 cells (Fig. 6D-E). We found that AR with normal (24Q) and expanded (65Q) polyglutamine localized to the cytosolic (Fig. 6A), mitochondrial (Fig. 6B) and nuclear fractions (Fig. 6C). To confirm the efficacy of the fractionation and purity of the lysates, we probed for tubulin, porin and HDAC1 as markers of cytosol, mitochondria and nucleus, respectively. As further confirmation of the purity of these fractions, we detected SOD2 and complex IV only in the mitochondrial fractions.
###end p 30
###begin p 31
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 91 92 91 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1446 1447 1446 1447 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1448 1449 1448 1449 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1711 1712 1711 1712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1883 1884 1883 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 605 610 <span type="species:ncbi:10090">mouse</span>
###xml 1004 1009 <span type="species:ncbi:10090">mouse</span>
###xml 1411 1416 <span type="species:ncbi:9606">human</span>
Altered subcellular distribution of androgen receptor. Cytosolic (A and D), mitochondrial (B and E) and nuclear (C) fractions were probed for AR in vehicle-treated and R1881-exposed parental, AR-24Q and AR-65Q MN-1 cells (A-C) and in differentiated vehicle-treated PC12 cells (D and E). To confirm the purity of the fractions, we used antibodies for tubulin (cytosol), porin (mitochondria) and HDAC1 (nucleus). HDAC1 and tubulin were not detected in the mitochondrial fractions, and porin was not detected in the cytosolic and nuclear fractions (latter not shown). Heart mitochondrial lysate and knock-in mouse testis tissue lysates were used as negative and positive controls for AR. The parental samples, which do not express AR, were also a negative control. Sample assignments in the gels (A-C) are: lane 1, parental vehicle-treated MN-1; lane 2, vehicle-treated AR-24Q; lane 3, AR-24Q+R1881; Lane 4, vehicle-treated AR-65Q; lane 5, AR-65Q+R1881; lane 6, heart mitochondrial lysate; lane 7, knock-in mouse testis tissue lysate. (D and E) Lane 1, vehicle-treated Dox-induced parental cells; lane 2, vehicle-treated uninduced AR-10Q; lane 3, vehicle-treated Dox-induced AR-10Q; lane 4, Dox-induced AR-10Q+R1881; lane 5, Dox-induced AR-10Q+DHT; lane 6, vehicle-treated uninduced AR-112Q; lane 7, vehicle-treated Dox-induced AR-112Q; lane 8, Dox-induced AR-112Q+R1881; lane 9, Dox-induced AR-112Q+DHT; lane 10, human heart mitochondrial lysate. (F-H) Electron dense immunogold particles indicate AR in AR-24Q (F) and AR-65Q (G) MN-1 cells exposed to vehicle alone. 10 000x electron micrographs (F and G) show mitochondria with (arrows) or without (arrowheads) associated AR in AR-24Q (F) and AR-65Q cells (G). (H) The percentage of mitochondria with associated AR is higher in AR-65Q cells. The histogram represents averages from 10 to 12 cells, with the error bars indicating SEM; *P </= 0.05.
###end p 31
###begin p 32
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
###xml 353 354 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 422 423 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F6">6</xref>
To examine the exact localization of AR in mitochondria, we did ultrastructural studies using transmission electron microscopy (Fig. 6F and G). Immunogold labeling for AR in MN-1 cells showed that AR localized within the organelle as well as along the membrane. Quantitative assessment showed an increased number of AR-positive mitochondria (56 +/- 3%; P </= 0.001) in the AR-65Q MN-1 cells compared to AR-24Q cells (Fig. 6H). Thus, the results from both subcellular fractionation and ultrastructural studies indicate that AR associates with mitochondria.
###end p 32
###begin title 33
Attenuation of cell death in MN-1 cells with mitochondrial modulators
###end title 33
###begin p 34
###xml 197 198 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 294 295 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 325 326 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 360 361 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 421 422 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 439 440 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F7">7</xref>
###xml 756 757 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 774 775 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F7">7</xref>
###xml 843 844 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 875 876 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 912 913 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 946 947 908 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We then investigated whether CsA and antioxidants rescue mutant AR-induced cell death, using loss of membrane integrity as a measure of cell viability. We observed that the increase of 61 +/- 11% (P </= 0.01) caused by the expression of mutant AR in MN-1 cells was mitigated by CsA (21 +/- 4%; P </= 0.01), CoQ10 (31 +/- 6%; P </= 0.01), idebenone (24 +/- 6%; P </= 0.01) and the pan-caspase inhibitor, z-VAD (26 +/- 9%; P </= 0.01) (Fig. 7A). Although ligand-dependent toxicity has been found in other models of SBMA, we found that exposure of the cells stably expressing AR-65Q to ligands did not exacerbate cell death (data not shown). However, when mutant AR expression was induced in PC12 cells, ligand exposure increased cell toxicity by 43 +/- 10% (P </= 0.01) (Fig. 7B). The ligand-dependent toxicity was reversed by z-VAD (53 +/- 7%; P </= 0.001), CoQ10 (65 +/- 7%; P </= 0.001), idebenone (55 +/- 11%; P </= 0.001) and CsA (56 +/- 10%; P </= 0.001). Staurosporine, an apoptotic inducer, increased cell death by 3-fold (data not shown).
###end p 34
###begin p 35
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 519 520 517 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1139 1140 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Cell death in AR-65Q MN-1 cells and AR-112Q PC12 cells is attenuated by treatment with mitochondrial modulators. (A) AR-24Q and AR-65Q MN-1 cells were analyzed for cell toxicity by propidium iodide staining and FACS. Relative to the AR-24Q cells (assigned as 100%), the vehicle-treated AR-65Q cells had increased toxicity. This increase was attenuated by treatment with CsA, CoQ10, idebenone and z-VAD. The histogram represents two experiments each done in triplicate, with error bars indicating the SEM; *P </= 0.05. (B) Differentiated PC12 cells induced to express AR-10Q and AR-112Q were exposed to vehicle control, R1881, the pan-caspase inhibitor, z-VAD, CoQ10, idebenone or CsA were analyzed for cell toxicity by propidium iodide staining and FACS. Vehicle-treated AR-112Q cells did not show toxicity relative to the vehicle-treated AR-10Q cells (assigned as 100%). PC12 cells expressing AR-112Q cells exposed to R1881 had increased cell toxicity. This increase was attenuated by treatment with CsA, CoQ10, idebenone and z-VAD. The histogram represents three experiments each done in triplicate, with error bars indicating the SEM; *P </= 0.001.
###end p 35
###begin p 36
In conclusion, we show that mitochondrial number and function are altered in cell models of SBMA. Treatment of the cells with CsA and antioxidants rescues cells from the toxicity induced by mutant AR. Therefore, we propose that mitochondrial dysfunction is at least in part responsible for the toxicity of mutant AR in SBMA.
###end p 36
###begin title 37
DISCUSSION
###end title 37
###begin p 38
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C16">16</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C18">18</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C19">19</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C50">50</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C51">51</xref>
###xml 940 941 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN310F8">8</xref>
###xml 573 578 <span type="species:ncbi:10090">mouse</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
Mitochondrial abnormalities and oxidative stress-mediated neuronal toxicity have been implicated in many neurodegenerative diseases, including ALS and HD (16,18,19,50,51). Here we studied mitochondrial dysfunction in SBMA. We found that the expression of mutant AR is associated with activation of the mitochondrial caspase pathway, decreased MtMP, elevated ROS levels and increased cell death. These changes were mitigated with CsA and antioxidants. We also report consistent decreases in PGC-1beta mRNA and in SOD2 mRNA and protein. Altered gene expression in a knock-in mouse model of SBMA was evident in pre-manifesting mice, suggesting that mitochondrial abnormalities and redox imbalance occur early in the disease mechanism. Interestingly, we found AR associated with the mitochondria in MN-1 and PC12 cells. Taken together, the evidence supports both indirect and direct effects of mutant AR on mitochondrial function in SBMA (Fig. 8).
###end p 38
###begin p 39
Mechanism of mitochondrial dysfunction in SBMA. Mitochondrial mass, number and membrane potential are likely affected by mutant AR indirectly through ligand-dependent alterations in mitochondrial gene expression and directly through association of AR with mitochondria. The decrease in MtMP is blocked by CsA. Downstream from the mitochondrial dysfunction, mutant AR increases ROS levels, which can reversibly result in further deleterious effects on the mitochondrial membrane. The antioxidants CoQ10 and idebenone block the increase in ROS levels. Mitochondrial dysfunction increases caspase 9 activity, which in turn increases caspase 3 activity. Elevated ROS levels and caspase 3 activation result in cell death. Activation of the caspases is mitigated by CsA, and cell death is attenuated by CsA, CoQ10, idebenone and the caspase inhibitor, z-VAD. Thus, regardless of the cause of mitochondrial dysfunction, downstream events may be targets for therapeutic intervention, for example with CsA and antioxidants.
###end p 39
###begin p 40
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C9">9</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C10">10</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C12">12</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C14">14</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C52">52</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C23">23</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C49">49</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C53">53</xref>
###xml 1018 1020 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C54">54</xref>
###xml 1223 1225 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C53">53</xref>
###xml 1226 1228 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C55">55</xref>
###xml 2339 2341 2311 2313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C56">56</xref>
###xml 2342 2344 2314 2316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C57">57</xref>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 1664 1668 <span type="species:ncbi:10090">mice</span>
###xml 2152 2156 <span type="species:ncbi:10090">mice</span>
###xml 2231 2236 <span type="species:ncbi:10090">mouse</span>
SBMA is characterized by both a loss of normal AR function and a toxic gain of function. It is well established that there is transcriptional dysregulation due to partial loss of AR function and to ligand-dependent toxicity (9,10,12-14). The effects of mutant AR on mitochondrial function that we found were both ligand-dependent and -independent. Although previous studies identified gene expression changes in the presence of mutant AR (52), transcriptional effects on either nuclear-encoded mitochondrial genes or transcription of the mitochondrial DNA have not previously been reported. It is likely that mutant AR alters the expression of mitochondrial genes, and this in turn may affect mitochondrial turnover and respiratory function. The nuclear co-activator, PGC-1, is known to regulate mitochondrial biogenesis and function (23,49,53). PGC-1alpha knock-out mice have impaired energy homeostasis, hyperactivity, striatal degeneration and behavioral changes characteristic of movement disorders, including HD (54). PGC-1alpha and beta regulate oxidant-detoxifying enzymes and also the expression of mitochondrial transcription factor A (Tfam), a direct regulator of mitochondrial DNA replication and transcription (53,55). We could not detect the expression of PGC-1alpha in MN-1 cells, but transcript levels of its isoform PGC-1beta and Tfam were significantly decreased, and this could account for the reduced mitochondrial number and membrane potential that we observed. In addition, expression of cellular antioxidants, such as SOD2, was altered in MN-1 cells, consistent with increased oxidative stress. In pre-manifesting (1 month old) SBMA knock-in mice, we found alterations in transcripts that regulate mitochondrial biogenesis (PGC-1alpha, PGC-1beta and Tfam), metabolism (subunits of complex I and IV that are encoded by the mitochondrial DNA) and antioxidants. This indicates that mitochondrial alterations and oxidative imbalance are early and important events in SBMA. It is also noteworthy that the transcript levels of ND1 and ND5 are decreased concurrent with decreased PGC-1beta and Tfam in the manifesting (5 month old) SBMA mice. This suggests that the metabolic demand increases in the tissues of this mouse model as the disease progresses. Also, consistent with the previously reported pathological findings (56,57), the greatest changes occurred in muscle and testis early in the disease and persisted as the disease progressed. Future investigations are warranted to examine whether mutant AR alters bioenergetics and whether it does so by indirectly or directly affecting the activity of the electron transport chain and ATP levels.
###end p 40
###begin p 41
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C58">58</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C61">61</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C62">62</xref>
###xml 1292 1294 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C20">20</xref>
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C63">63</xref>
Previous studies have shown the localization of steroid and thyroid hormone receptors to mitochondria (58-61). Hormone response elements in the mitochondrial genome and metabolic effects of glucocorticoids and estrogens suggest a direct action of these hormones on mitochondria (62). We are unaware of previous reports of normal or mutated AR localized to neuronal mitochondria. We found mitochondria-associated AR in MN-1 cells, which have constitutive expression of AR, and also in the inducible PC12 cells that express normal and mutant AR at comparable levels. This supports the conclusion that the association is not simply due to clonal variation or differences in the relative levels of AR expression. Although the association of AR with mitochondria that we found is not limited to the mutant form, it is likely that the presence of the expanded polyglutamine-containing AR directly confers a toxic gain of function resulting in mitochondrial abnormalities and oxidative imbalance. These results suggest that the mitochondrial defects may be due to both transcriptional events mediated by the nucleus and a direct toxic effect of the mutant AR on the mitochondria. The mutant proteins that cause HD and spinocerebellar ataxia 3 have also been reported to associate with mitochondria (20,63) suggesting that the mitochondrial association of the mutant proteins in polyglutamine expansion diseases may point towards a common pathogenic mechanism. Our finding that AR localizes to mitochondria in both MN-1 and PC12 cells may have important implications in understanding normal AR function and its role in disease.
###end p 41
###begin p 42
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C51">51</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C64">64</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C66">66</xref>
###xml 1229 1237 1229 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1490 1492 1490 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C67">67</xref>
It has not previously been well documented that mutant AR affects mitochondrial number and function. However, it has been reported in other neurological disorders that excitotoxicity and other insults cause mitochondria to undergo vesiculation of the cristae, vacuolation and fragmentation (51,64-66). Although in our study we cannot definitively demonstrate fragmentation, our results do indicate that the expanded polyglutamine in AR alters mitochondrial number and morphology of the cristae. The reduced number of mitochondria in PC12 cells induced to express mutant AR indicates that the decrease in MN-1 cells is not simply an adaptive change related to constitutive expression of the mutant protein. Mitochondrial number can be affected by differences in cellular proliferation or passage numbers of the clones. However, the different experimental conditions did not induce any variation in cellular proliferation, and we controlled for possible differences due to different passage numbers of the different clones. The vesiculation and vacuolation that we observed in the AR-65Q cells could be due to mitochondrial toxicity or vice versa. The mitochondrial membrane depolarization and the response to CsA treatment in the in vitro models of SBMA are further evidence for the role of mitochondrial dysfunction and the MTP in SBMA. The protective effect of CsA suggests but does not prove the involvement of the MTP, because CsA also has other effects, such as calcineurin inhibition (67). The effects we found on MtMP were both ligand-dependent and -independent. In light of these results, the effects of the mutant AR on mitochondrial mass, number and membrane potential may be due either to indirect nuclear-encoded transcriptional effects on mitochondria or to direct toxic interactions of the expanded polyglutamine with mitochondria. However, these are not mutually exclusive, as the disease mechanism could involve a combination of both effects.
###end p 42
###begin p 43
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C21">21</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C68">68</xref>
###xml 740 747 740 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C69">69</xref>
###xml 1029 1031 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C70">70</xref>
###xml 1645 1647 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C71">71</xref>
###xml 1648 1650 1645 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C74">74</xref>
###xml 2770 2778 2767 2775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 888 903 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2052 2057 <span type="species:ncbi:10090">mouse</span>
###xml 2897 2902 <span type="species:ncbi:10090">mouse</span>
Regardless of the cause of mitochondrial dysfunction, we found that the effects of the mutant AR include increased ROS, increased Bax protein levels, activation of caspases 9 and 3 and increased cell death. The mitochondrial abnormalities described in this study may be an important modifier of the pathogenic process, where the ligand-dependent effect of the mutant AR on transcription is likely to be exacerbated by a direct effect on mitochondria. The mitochondrial dysfunction may then tip the cell towards the activation of the caspase cascade and death. Alterations in oxidative phosphorylation may result in the generation of ROS and elevated oxidative stress (21,68). Also, increased ROS generation may further damage mitochondria. In vivo deletion of SOD2 in mice results in mitochondrial pathology and shortens lifespan (69). In another study, partial reduction of SOD2 in hAPP transgenic mice accelerates the onset of beta amyloid-induced behavioral impairment and significantly worsens Alzheimer's disease pathology (70). We did not see a general decrease in transcript levels of cellular antioxidants, but the mitochondrial antioxidant, SOD2, was specifically and consistently reduced in all three affected tissues, indicating the importance of mitochondria-associated oxidative stress in SBMA. This oxidative imbalance can further result in mitochondrial membrane changes that initiate the intrinsic caspase cascade involving activation of caspases 9 and 3. Our results support cytochrome C release- and Bad-independent activation of caspase 9, consistent with previous reports of cytochrome C independent activation of caspase 9 (71-74). In addition our findings that the increase in Bax and caspase 3 activation is polyglutamine-dependent while caspase 9 activation is ligand-dependent also suggest involvement of other pathways in the activation of caspase 9. Post-translational modifications such as phosphorylation or the release of Smac/Diablo can mediate caspase 9 activation. Further studies of these pathways in cell culture and mouse tissues may be warranted. The finding that CsA mitigates MtMP changes and the activation of caspases 9 and 3 indicates that the expression of the mutant AR is associated with mitochondrial dysfunction, which can be reversed by pharmacological intervention. Importantly, treating these cells with antioxidants was effective not only in mitigating the increase in ROS but also in blocking cell death caused by the expression of mutant AR. While cell death in the MN-1 cells was dependent on mutant polyglutamine but not ligand, the toxicity of mutant AR in PC12 cells was ligand-dependent. With constitutive expression of AR-65Q, the mutant MN-1 clone may have adapted to cope with ligand-dependent effects. These in vitro studies warrant follow-up studies in tissue mitochondria and pre-clinical therapeutic studies of antioxidants in SBMA mouse models.
###end p 43
###begin p 44
While we do not differentiate between primary and secondary roles of mitochondrial defects in SBMA pathogenesis, we propose that mitochondrial dysfunction and dysregulation of the antioxidant defense are important in the disease mechanism. Given the central role of mitochondrial integrity in bioenergetics and cell death pathways, improvement of mitochondrial function is worth considering as a therapeutic approach to SBMA.
###end p 44
###begin title 45
MATERIALS AND METHODS
###end title 45
###begin title 46
Reagents
###end title 46
###begin p 47
All cell culture reagents were purchased from Invitrogen (Gaithersburg, MD) unless otherwise mentioned. The non-aromatizable synthetic ligand R1881 and the natural ligand dihydrotestosterone were purchased from Sigma-Aldrich (St Louis, MO, USA). 5,5',6,6'-tetrachloro-1,1,3,3-tetraethylbenzimidazolcarbocyanine iodide (JC-1), tetramethyl rhodamine methyl ester (TMRM), MitoTracker Green FM and DHR 123 were obtained from Molecular Probes (Gaithersburg, MD, USA). The other compounds used in the study were nerve growth factor (NGF; BD Biosciences), doxycycline (Dox) (Sigma), CsA (Sigma), co-enzyme Q10 (CoQ10) (Sigma), idebenone (Santhera Pharmaceuticals, Switzerland), purified caspase 9 enzyme and caspase 9 inhibitor (Ac-LEHD-CHO; BIOMOL), caspase 9 inhibitor (z-LEHD-FMK; Alexis Biologicals), pan-caspase inhibitor (z-VAD-FMK; BD Pharmingen), staurosporine (STS; Calbiochem), p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP; Sigma), antimycin A (Sigma), hydrogen peroxide (Fisher Scientific) and propidium iodide (PI; Sigma).
###end p 47
###begin title 48
Cell culture
###end title 48
###begin p 49
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C15">15</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C35">35</xref>
###xml 443 444 443 444 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 444 445 444 445 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 519 520 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 882 884 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C35">35</xref>
###xml 984 986 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C52">52</xref>
###xml 1491 1492 1484 1485 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1513 1514 1506 1507 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1514 1515 1507 1508 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1633 1634 1616 1617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2335 2336 2314 2315 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2348 2349 2327 2328 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2360 2361 2339 2340 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2372 2373 2351 2352 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2386 2387 2365 2366 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2407 2408 2382 2383 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2420 2421 2395 2396 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2443 2444 2414 2415 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2464 2465 2431 2432 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2627 2628 2594 2595 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 111 114 <span type="species:ncbi:10116">rat</span>
###xml 390 396 <span type="species:ncbi:9913">bovine</span>
###xml 1234 1237 <span type="species:ncbi:10116">rat</span>
###xml 1401 1406 <span type="species:ncbi:9796">horse</span>
Stably transfected mouse spinal cord motor neuron-derived hybrid (MN-1) cells and stably transfected inducible rat pheochromacytoma (PC12) cells of SBMA were cultured as previously described (15,35). The PC12 cells were provided by Dr Diane Merry (Thomas Jefferson University, PA, USA). MN-1 cells were maintained in normal growth medium (Dulbecco's Modified Eagle's Medium) with 10% fetal bovine serum (FBS; Atlanta biologicals, GA, USA), 2 mml-glutamine and 100 units/ml penicillin/streptomycin at 37degreesC in 5% CO2. The MN-1 clones constitutively expressing either the full-length wild-type AR with 24 glutamines (AR-24Q) or the full-length mutant AR with 65 glutamines (AR-65Q) were grown in the same medium supplemented with 350 mug/ml G418. It has been demonstrated that in the absence of ligand, the mutant protein is expressed at lower levels than the wild-type protein (35). The steady-state levels of both forms of the protein are increased with the addition of ligands (52). We used DHT, the natural ligand and R1881, the synthetic non-metabolizable ligand for our experiments. We did not see any difference in the effects of DHT and R1881 at the concentrations used in this study. The parental PC12 cells were grown on rat tail collagen I [0.01% w/v in 0.1 M glacial acetic acid / 1X phosphate-buffered saline (PBS)] coated dishes. Cells were cultured in DMEM with 10% heat inactivated horse serum (HyClone, UT), 5% tetracycline-negative FBS (Tet- FBS; Clontech, CA, USA), 1 mm sodium pyruvate, 2 mml-glutamine, 100 units/ml penicillin/streptomycin, 200 microg/ml hygromycin B (complete medium) at 37degreesC in 10% CO2. The AR-10Q and AR-112Q PC12 clones were maintained in the complete medium supplemented with 100 microg/ml G418. PC12 cells were differentiated with 200 ng/ml NGF for 1 day and all experiments were done while maintaining the cells in a differentiated state. The MN-1 cells were not differentiated. All experiments in MN-1 and PC12 cells were done in complete medium containing 10% charcoal dextran stripped (CDSFBS) (HyClone, UT, USA). The experiments with PC12 cells were done in complete medium but replacing the Tet- FBS with CDSFBS and in the presence of 200 ng/ml NGF. The cells were either left uninduced or induced with 10 ng/ml of Dox. Unless otherwise mentioned, cells were treated with 10 nm R1881, 10 nm DHT, 250 nm CsA, 200 nm CoQ10, 200 nm idebenone, 10 microm FCCP, 250 nm Ac-LEHD-CHO, 10 microm z-LEHD-FMK, 5 microm z-VAD for either 24 or 48 h. As positive controls for different assays, we used the mitochondrial toxin, antimycin A (200 or 500 ng/ml), hydrogen peroxide (500 nm) and the apoptotic inducer, staurosporine (1 microm) for 16-18 h and 4 h, respectively.
###end p 49
###begin title 50
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model
###end title 50
###begin p 51
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C56">56</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C57">57</xref>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
The generation and characterization of the knock-in mouse model of SBMA (AR-21Q and AR-113Q) has been previously described (56,57). Breeder mice were provided by Drs A.P. Lieberman and D. Robins (University of Michigan, MI, USA). The colonies of mice with the non-pathological repeat length of glutamines knocked in the AR (AR-21Q; normal) were maintained by mating homozygotes. Male mice with 113 glutamines knocked in the AR (AR-113Q; mutant) males are infertile and hence the mutant mice colonies were maintained by mating females heterozygous for the targeted allele with wild-type C57BL/6J males. All experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were approved by the National Institute of Neurological Disorders and Stroke Animal Care Committee. Tail DNA genotyping was done using the REDExtract-N-AMP tissue PCR kit (Sigma). The primers used for the genotyping were 5'-ggaagtgcagttagggctggga and 5'-gacactgccttacacaactccttggc.
###end p 51
###begin p 52
###xml 25 29 <span type="species:ncbi:10090">mice</span>
For biochemical studies, mice were anesthetized with isoflurane and sacrificed by cervical dislocation. Spinal cord, hind limb skeletal muscle and testes were dissected and snap frozen in liquid nitrogen. The tissues were stored at -80degreesC and thawed on ice immediately prior to RNA and protein extraction.
###end p 52
###begin title 53
Caspase 9 and caspase 3 assays
###end title 53
###begin p 54
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 959 960 951 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1306 1307 1294 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Caspase 9 activity was assessed with the Caspase-Glo 9 assay as per the manufacturer's protocol (Promega). MN-1 cells were seeded in 24-well plates at 6 x 104 cells/well. Cells were exposed to vehicle alone or androgen ligands (R1881 or DHT), and treated with or without caspase 9 inhibitor (Ac-LEHD-CHO; Biomol) and CsA. After 48 h, cells were trypsinized and centrifuged at 800g for 5 min. The cell pellets were washed in 1X PBS and re-suspended in 200 microl of 1X PBS. Half of the cell suspension was transferred to a 96-well plate for the luminescence assay and the other half of the suspension was used to determine total protein concentration. Purified caspase 9 enzyme (100 units/ml) was used as a positive control, and the vehicle control was used as a blank for the assay. Caspase-Glo 9 reagent (100 microl) was added to each sample in the 96-well plate; the samples were incubated for 1 h at room temperature and luminescence measured with a Victor3 multi-well luminometer (Perkin Elmer, MA, USA). The luminescence is a direct measure of the caspase 9 activity and was normalized to total cellular protein. An equal volume of the Mammalian Protein Extraction Reagent (M-PER; Pierce Biotechnology) was added to the 100 microl cell suspension to lyse the cells, and following centrifugation at 800g for 7 min the lysate was used to determine the protein concentration by the MicroBCA Protein Assay method as per manufacturer's protocol (Pierce Biotechnology).
###end p 54
###begin p 55
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C31">31</xref>
###xml 361 362 357 358 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Caspase 3 activity was measured with two different assays. In the first, caspase 3 activity was determined by the ApoTarget fluorometric assay (Biosource International) according to manufacturer's instructions and a published protocol (31). Another caspase 9 inhibitor (z-LEHD-FMK) and pan-caspase inhibitor (z-VAD) were used at concentrations of 10 and 5 microm, respectively. Protein concentrations were estimated on parallel samples using the bicinchoninic acid protein assay method.
###end p 55
###begin p 56
###xml 639 640 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
In an independent caspase 3 assay, the activity was measured with MitoCasp (Cell Technology, CA, USA) as per manufacturer's instructions. Briefly, cells grown in 24-well dishes and treated for 48 h were stained with the MitoCasp reagents for 1 h at 37degreesC. After PBS washes and centrifugation, the re-suspended pellets were transferred to a black-wall 96-well plate. The caspase 3 activity was determined with a fluorescent-based assay wherein carboxyfluorescein (FAM)-labeled fluoromethyl ketone (FMK)-peptide inhibitors bind to active caspases and fluoresce green (emission peaks at 510 nm). The fluorescence was measured in a Victor3 multi-well plate fluorometer and was normalized to total protein content as described earlier (see caspase 9 activity assay).
###end p 56
###begin title 57
Mitochondrial mass
###end title 57
###begin p 58
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 190 191 190 191 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 300 302 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C75">75</xref>
###xml 372 373 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
MN-1 and PC12 cells were seeded at 2.5 x 105 and 3 x 105 cells/well, respectively, in 6-well dishes. Following 48 h exposure to vehicle or androgen ligands, the cells were stained with 100 nm MitoTracker Green FM (MTG) in complete medium prepared using phenol-red free DMEM for 30 min at 37degreesC (75). After trypsinizing the adherent cells, they were centrifuged at 800g for 5 min at room temperature. The pellets were washed twice in PBS supplemented with 0.5% FCS and re-suspended in 400 microl PBS/0.5% FCS. Green fluorescent cells were analyzed by flow cytometry (Becton Dickinson FACS Calibur) using 488 nm laser excitation and 530/30 nm MTG emission and Cell Quest software (Becton Dickinson). A total of 100,000 cells were analyzed in each sample. Cell populations were gated by size (forward scatter) and granularity (side scatter) to exclude debris and cell clumps for all samples. An unstained negative control sample and a positive control sample of normal cells stained with the MTG were used to establish a 100% positive reference region. Experimental samples stained with MTG were then evaluated for the percent green fluorescent cells in the reference region.
###end p 58
###begin title 59
Mitochondrial membrane potential (MtMP)
###end title 59
###begin p 60
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C45">45</xref>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C76">76</xref>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 555 556 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 682 683 682 683 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 751 752 747 748 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 804 805 796 797 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 961 962 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
MtMP was determined as per published protocols (45,76). The lipophilic cation JC-1 was used to obtain ratiometric determinants of membrane potential using flow cytometry (Becton Dickinson FACS Calibur) and Cell Quest software (Becton Dickinson). Lower potential causes JC1 to remain in a monomeric form with low amounts in the mitochondria and fluoresce green. In contrast, when the mitochondrial membranes are energized, the dye forms J-aggregates, accumulates in the mitochondria and fluoresces red. MN-1 and PC12 cells were seeded at 2 x 105 and 3 x 105 cells/well, respectively, in 6-well dishes. The cells were exposed to vehicle alone or androgen ligands with or without 250 nm CsA for 48 h. As a positive control, cells were exposed to 10 microm FCCP for 24 h. Cells were then stained with 5 microm JC-1 in complete medium prepared with phenol-red free DMEM for 40 min at 37degreesC. Adherent cells were collected by trypsinization and centrifuged at 800g for 5 min at room temperature. The pellets were then washed twice in PBS supplemented with 0.5% FCS and re-suspended in 400 microl PBS/0.5% FCS before analysis by flow cytometry. A total of 50,000 cells were analyzed. The degree of mitochondrial membrane depolarization was calculated as the ratio of depolarized (green) to polarized (red) signals from the dot plots.
###end p 60
###begin p 61
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C76">76</xref>
###xml 513 514 513 514 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 645 646 641 642 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 691 692 687 688 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1073 1074 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C3">3</xref>
In an independent assay, MtMP was determined using the fluorochrome TMRM, which localizes to mitochondria and detects membrane potential. This was normalized to total number of mitochondria, as measured with MTG, which labels all mitochondria irrespective of their functional state (76). The ratio between TMRM and MTG fluorescence indicates MtMP normalized to the number of mitochondria. Briefly, cells in 6-well dishes were exposed to vehicle alone, or to androgen ligands (R1881 and DHT), or treated with 250 nm CsA for 48 h. As a positive control for membrane depolarization, cells were exposed to the mitochondrial uncoupler, FCCP (10 microm) for 24 h. They were then stained with 100 nm each of TMRM and MTG for 30 min at 37degreesC. Following trypsinization and centrifugation, the cells were washed twice with PBS to remove excess fluorochrome, re-suspended in 1X PBS and gently lysed with 1% (v/v) Triton X-100. The relative fluorescence for TMRM (excitation, 550 nm; emission, 590 nm) and MTG (excitation, 405 nm; emission, 515 nm) was measured using the Victor (3) multi-well plate fluorometer.
###end p 61
###begin title 62
ROS assay
###end title 62
###begin p 63
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 341 342 341 342 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 395 396 395 396 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 549 550 545 546 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 827 828 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
ROS levels were measured in cell lines using fluorescence-based assays. MN-1 and PC12 cells were seeded at 6 x 104 and 1 x 105 cells/well, respectively, in 24-well dishes. These cells were either exposed to vehicle or androgen ligands for 48 h. As positive controls, the cells were treated for 16 h each with 200 ng/ml antimycin A, and 500 nm hydrogen peroxide. They were also treated with 200 nm each of the antioxidants CoQ10 and idebenone. After 48 h of treatment, the cells were loaded with the probe, DHR 123 at a final concentration of 5 microm. DHR 123 is an oxidation-sensitive lipophilic dye that enters a cell, localizes to the mitochondria and fluoresces when oxidized by mitochondrial ROS to positively charged derivatives. Cell fluorescence with a peak emission of 530 nm was measured in lysed cells using a Victor3 multi-well plate fluorometer. The relative fluorescence units (RFU) were normalized to total protein content, which was determined as for the caspase assays described earlier.
###end p 63
###begin title 64
RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR)
###end title 64
###begin p 65
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C77">77</xref>
###xml 1298 1299 1298 1299 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1516 1518 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C78">78</xref>
###xml 2280 2281 2280 2281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2307 2308 2307 2308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2339 2340 2339 2340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2365 2366 2365 2366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2412 2413 2412 2413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2438 2439 2438 2439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 1755 1759 <span type="species:ncbi:10090">mice</span>
###xml 1927 1931 <span type="species:ncbi:10090">mice</span>
###xml 1978 1982 <span type="species:ncbi:10090">mice</span>
###xml 2056 2060 <span type="species:ncbi:10090">mice</span>
###xml 2224 2228 <span type="species:ncbi:10090">mice</span>
Total RNA was isolated from MN-1 cells (1 x 106) exposed to vehicle control or the androgen ligands (16-24 h) and from about 40-60 mg of mouse tissues as per a previously published protocol (77). Briefly, the RNA was extracted using TRIzol (Invitrogen) and further purified using the RNAeasy clean-up kit according to the manufacturer's protocol (QIAGEN). Isolated RNA was first reverse transcribed to cDNA using random hexamer primers with the High Capacity cDNA Archive kit (Applied Biosystems, CA, USA). The qRT-PCR reactions were performed in triplicate with SYBR Green PCR core reagents using the ABI Prism 7900 Sequence Detector System (Applied Biosystems). Each of the primer sets demonstrated amplification, with no amplification of the negative controls. Since SYBR Green can bind primer dimers and produce non-specific signal, melting curves were generated for all primer sets in all experiments to ascertain specificity of amplified products. Target gene primer pairs are listed in . cDNA transcribed with known concentrations of RNA was diluted at 2-fold series to generate a standard curve for each primer set according to the cycle of threshold value obtained from real-time PCR. Primer efficiencies were estimated from the standard curves. Based on the standard curves, we used 300 nm each of the forward and reverse primers and 3 ng of the template for all experiments. Transcript levels were normalized to the loading control, S18 rRNA. Relative gene expression was determined by the Pfaffl method (78). The parental MN-1 cells, vehicle treated AR-24Q and AR-65Q clones were set to 1. The transcript levels of ligand-exposed AR-24Q and AR-65Q cells were compared to the respective vehicle treated samples. In the analysis of the knock-in mice, the non-pathological (AR-21Q; normal) and pathological (AR-113Q; mutant) samples were normalized to the AR-113Q wild-type littermates. Gene expression in the AR-113Q mice was calculated relative to that of the AR-21Q mice, which was assigned as 1. For the study, we used 1 month and 5 month old mice, and all experiments were conducted at least twice with each condition in triplicate. The numbers of 1 month old (pre-manifesting) and 3-5 month old (manifesting) mice used in the study were as follows: AR-21Q 1 month (n = 10) and 3-5 month old (n = 7); AR-113Q mutant 1 month (n = 9) and 3-5 month old (n = 4); AR-113Q wild type littermates 1 month (n = 6) and 3-5 month old (n = 7).
###end p 65
###begin title 66
Immunocytochemistry and confocal microscopy
###end title 66
###begin p 67
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 307 311 <span type="species:ncbi:9925">goat</span>
MN-1 cells were seeded in two-chamber CC2-coated slides (Lab-Tek; NUNC) at 105 cells/well and exposed to vehicle control or R1881 for 48 h. They were then fixed in ice cold 4% paraformaldehyde at room temperature for 20 min, permeabilized with 0.1% Triton X-100 in PBS for 15 min and blocked with 5% normal goat serum for 1 h. The samples were incubated with polyclonal antibodies to SOD2 (4 microg/ml; SOD-110, Stressgen) and Hsp60 (1:150; Santa Cruz Biotechnology). Following washes in 1X PBS, they were incubated with FITC and Texas red conjugated secondary antibodies (Jackson Immuno-Research Laboratories), washed and mounted using DAPI-containing Vectashield mounting media (Vector Labs). Deconvoluted images were acquired with a Zeiss LSM510 laser scanning confocal microscope.
###end p 67
###begin title 68
Total cell protein extraction, sub-cellular fractionation and immunoblotting
###end title 68
###begin p 69
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 479 480 475 476 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 640 641 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
MN-1 and PC12 cells were seeded in 10 cm dishes at 8 x 105 and 1 x 106 cells/dish, respectively. They were exposed to vehicle alone or the androgen ligands for 48 h. The cells were then trypsinized and centrifuged at 800g for 7 min, and the pellets were washed twice in cold 1X PBS. For total cell lysates, the pellets were re-suspended in 200 microl lysis buffer (0.01 M sodium phosphate, pH 7.2, 0.15 M NaCl, 0.1% sodium dodecyl sulfate, 1% sodium deoxycholate, 1% NP40 and 2 mm EDTA) with a protease inhibitor cocktail (Roche Diagnostics) and incubated on ice for 10 min. The lysates were then sonicated for 10 s and microfuged at 20 000g for 10 min at 4degreesC. The supernatant was then collected as the total cell lysate. Total tissue homogenate was prepared by homogenizing 50-70 mg of tissue in 500 microl lysis buffer and protein extracted following the protocol as described above.
###end p 69
###begin p 70
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 390 391 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Mitochondrial subcellular fractions were prepared from cells using the mitochondrial isolation reagents (Sigma) as per the manufacturer's protocol. Briefly, cells suspended in extraction buffer were homogenized in a Dounce homogenizer using 15 strokes. The samples were then microfuged at 1000g for 5 min at 4degreesC. The supernatant was transferred to a fresh tube and centrifuged at 3500g for 10 min at 4degreesC. The resulting supernatant was stored as the cytosolic fraction. The pellet was re-suspended in 100 microl CelLytic M cell lysis reagent (Sigma) and stored as the mitochondrial fraction. Nuclear fractionations were prepared using the NE-PER nuclear and cytoplasmic extraction reagents (Pierce Biotechnology) following the manufacturer's instructions. Total protein concentrations of all preparations were determined with the BCA protein assay kit (Pierce Biotechnology) according to the manufacturer's protocol.
###end p 70
###begin p 71
###xml 386 392 <span type="species:ncbi:9986">rabbit</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
###xml 506 512 <span type="species:ncbi:9986">rabbit</span>
###xml 565 571 <span type="species:ncbi:9986">rabbit</span>
###xml 632 638 <span type="species:ncbi:9986">rabbit</span>
###xml 690 696 <span type="species:ncbi:9986">rabbit</span>
###xml 736 741 <span type="species:ncbi:10090">mouse</span>
###xml 782 787 <span type="species:ncbi:10090">mouse</span>
###xml 845 850 <span type="species:ncbi:10090">mouse</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
###xml 951 956 <span type="species:ncbi:10090">mouse</span>
###xml 1023 1028 <span type="species:ncbi:9796">horse</span>
###xml 1029 1035 <span type="species:ncbi:3726">radish</span>
###xml 1058 1062 <span type="species:ncbi:9925">goat</span>
###xml 1068 1074 <span type="species:ncbi:9986">rabbit</span>
###xml 1083 1088 <span type="species:ncbi:10090">mouse</span>
###xml 1751 1755 <span type="species:ncbi:10090">mice</span>
For SDS-PAGE, protein lysates (100 microg) were denatured at 70degreesC in 4x sample buffer (Invitrogen) for 10 min, separated on 4-12% Tris-glycine acrylamide gels and electro-transferred to polyvinylidene fluoride (PVDF) membranes (Millipore). All immunoblotting procedures were carried out in 5% non-fat dry milk in 1x Tris-buffered saline (TBS). The antibodies used are as follows: rabbit anti-AR (N-20; sc-816, Santa Cruz Biotechnology; 1:1000), mouse anti-cytochrome C (MSA06; Mitosciences; 1:1000), rabbit anti-Bax (sc-493; Santa Cruz Biotechnology; 1:500), rabbit anti-phospho Bad (9295S; Cell Signaling Technology; 1:500), rabbit anti-Bad (9292; Cell Signaling Technology; 1:500), rabbit anti-SOD2 (SOD-110; Stressgen; 1:500), mouse anti-Hsp60 (SPA-829; Stressgen; 1:500), mouse anti-OxPhos complex IV (A6403; Invitrogen; 2 microg/ml), mouse anti-porin (A31855; Invitrogen; 0.5 microg/ml), mouse anti-alpha-tubulin (T9026; Sigma; 1:1000) and mouse anti-HDAC1 (89910; Pierce; 1:1000). Immunodetection was done with horse radish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG (1:15,000; Jackson Immunoresearch), and visualized with enhanced chemiluminescence reagent (Perkin-Elmer) following the manufacturer's instructions. Re-probing of the blots was done after stripping the blots with Re-blot Plus (Chemicon) according to manufacturer's protocol. Densitometric quantitation of the resultant bands was done with Image J software (NIH, Bethesda) and protein amounts were normalized to loading controls (tubulin for total lysates and cytosolic fractions, porin for mitochondria and HDAC1 for nuclear fractions). The values were normalized to the mean of the vehicle-treated MN-1 cells, uninduced normal PC12 cells or normal (AR-21Q) mice, which were each assigned as 1. Phosphorylated Bad was normalized to total Bad levels. Cytochrome C release was determined as the ratio of cytosolic to mitochondrial cytochrome C.
###end p 71
###begin title 72
Immuno-electron microscopy
###end title 72
###begin p 73
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C79">79</xref>
###xml 1578 1580 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C80">80</xref>
###xml 292 296 <span type="species:ncbi:9925">goat</span>
###xml 424 428 <span type="species:ncbi:9925">goat</span>
###xml 511 515 <span type="species:ncbi:9925">goat</span>
MN-1 cells were plated on Permanox chambered slides (Lab-Tek; Nunc) and exposed to vehicle control or the androgen ligands for 24 h. Cells for immunogold labeling were fixed with ice cold 4% paraformaldehyde in PBS for 1 h at room temperature followed by blocking and permeablization with 5% goat serum/0.1% saponin for 1 h. The cells were then incubated with anti-AR antibodies (1:100; N20, Santa Cruz Biotechnology) in 5% goat serum/0.1% saponin for 1.5 h at room temperature. After three 10 min washes in 1% goat serum/1X PBS and two 10 min washes in 2% dry milk, they were incubated with Nanogold-conjugated secondary antibody (1:250; Nanoprobes) for 1 h at room temperature. Following four 10 min washes in 2% dry milk/1X PBS the cells were fixed in 2% glutaraldehyde/1X PBS for 30 min. The slides were subjected to staining and silver enhancement as described previously (79). After dehydration, silver enhancement, embedding and sectioning, the samples were examined with an electron microscope (1200EX; JEOL). Electron micrographs of 12-15 cells were acquired and the mitochondria quantified by two independent researchers blinded to the source of the sample. The number of mitochondria per cell and the number of AR positive mitochondria were quantified. Immunogold particles appearing as electron dense dark spots within and in the peripheral areas (within 30 nm) of the mitochondria were counted as AR associated with the organelle. This distance was approximated based on the lengths of two approximately15 nm long IgG molecules separating the gold and the antigen (80).
###end p 73
###begin title 74
Cell death assays
###end title 74
###begin p 75
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN310C81">81</xref>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 243 244 239 240 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 288 289 284 285 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
We used a flow cytometry-based cell death assay as previously published (81). MN-1 and PC12 cells seeded at 2 x 105 and 3 x 105 cells /well in six well dishes were exposed to the vehicle control or the androgen ligands (R1881 and DHT), 1 microm staurosporine, 500 ng/ml antimycin A, 200 nm each of CsA, CoQ10 and idebenone. Except for staurosporine (4 h) and antimycin (16 h) treatments, the rest of the treatments were for 48 h. The cells were then trypsinized, gently pelleted and re-suspended in 1 ml of 1X PBS. The suspensions were then stained with 1 microg/ml propidium iodide (PI; Sigma) immediately before flow cytometry (Becton Dickinson FACS Calibur). For each sample, 80 000 non-gated events were acquired. PI fluorescence was analyzed in the FL-3 channel in dot and density blot formats. The results were expressed as a percentage of PI-positive dead cells divided by the total number of cells.
###end p 75
###begin title 76
Statistics
###end title 76
###begin p 77
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All experiments were conducted at least twice with each condition in triplicate. Comparisons between any two groups of data were done using the single-factorial analysis of variance (ANOVA). A P-value of </=0.05 was considered statistically significant. Numerical data were expressed as averages +/- the standard error of mean (SEM).
###end p 77
###begin title 78
SUPPLEMENTARY MATERIAL
###end title 78
###begin p 79
.
###end p 79
###begin title 80
FUNDING
###end title 80
###begin p 81
###xml 61 66 61 66 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NINDS</grant-sponsor>
###xml 75 94 75 94 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fondazione Telethon</grant-sponsor>
###xml 96 104 96 104 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP04005</grant-num>
###xml 112 150 112 150 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kennedy's Disease Association research</grant-sponsor>
The work was supported by intramural research funds from the NINDS, and by Fondazione Telethon (GFP04005) and a Kennedy's Disease Association research grant (to M.P.). Funding to pay the open access charges was provided by the intramural research funds from the NINDS.
###end p 81
###begin title 82
Supplementary Material
###end title 82
###begin title 83
[Supplementary Data]
###end title 83
###begin title 84
ACKNOWLEDGEMENTS
###end title 84
###begin p 85
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:9606">Human</span>
We are grateful to Drs Andrew Lieberman and Diane Robins for providing us with the knock-in mouse model and to Dr Diane Merry for the PC12 cell lines. We thank Martha Kirby in the National Human Genome Research Institute FACS Core Facility, Carolyn Smith with the National Institute of Neurological Disorders and Stroke (NINDS) imaging Core Facility and Susan Cheng and Virginia Crocker in the NINDS Electron Microscopy Core Facility. We thank the members of the Neurogenetics Branch, particularly Melanie Knight and Isabella Palazzolo for their helpful discussions. We also thank Santhera Pharmaceuticals for providing idebenone for this study.
###end p 85
###begin p 86
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. The authors declare no conflict of interest.
###end p 86
###begin title 87
REFERENCES
###end title 87
###begin article-title 88
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
###end article-title 88
###begin article-title 89
Trinucleotide repeat disorders
###end article-title 89
###begin article-title 90
Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA)
###end article-title 90
###begin article-title 91
Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease
###end article-title 91
###begin article-title 92
Clinical and molecular aspects of androgen receptor defects
###end article-title 92
###begin article-title 93
Reflections on the diseases linked to mutations of the androgen receptor
###end article-title 93
###begin article-title 94
The role of the polyglutamine tract in androgen receptor
###end article-title 94
###begin article-title 95
Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy
###end article-title 95
###begin article-title 96
###xml 83 93 <span type="species:ncbi:7227">Drosophila</span>
Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein
###end article-title 96
###begin article-title 97
CREB-binding protein sequestration by expanded polyglutamine
###end article-title 97
###begin article-title 98
Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives
###end article-title 98
###begin article-title 99
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy
###end article-title 99
###begin article-title 100
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
###end article-title 100
###begin article-title 101
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy
###end article-title 101
###begin article-title 102
Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy
###end article-title 102
###begin article-title 103
Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases
###end article-title 103
###begin article-title 104
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
###end article-title 104
###begin article-title 105
Mitochondrial dysfunction and amyotrophic lateral sclerosis
###end article-title 105
###begin article-title 106
Oxidative damage in Huntington's disease pathogenesis
###end article-title 106
###begin article-title 107
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
###end article-title 107
###begin article-title 108
Therapeutics development for triplet repeat expansion diseases
###end article-title 108
###begin article-title 109
Transcriptional control of energy homeostasis through the PGC1 coactivators
###end article-title 109
###begin article-title 110
Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators
###end article-title 110
###begin article-title 111
Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha
###end article-title 111
###begin article-title 112
Oxidative stress and transcriptional regulation in Alzheimer disease
###end article-title 112
###begin article-title 113
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
###end article-title 113
###begin article-title 114
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
###end article-title 114
###begin article-title 115
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration
###end article-title 115
###begin article-title 116
Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes
###end article-title 116
###begin article-title 117
###xml 47 52 <span type="species:ncbi:9606">human</span>
Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy
###end article-title 117
###begin article-title 118
Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity
###end article-title 118
###begin article-title 119
A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor
###end article-title 119
###begin article-title 120
Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity
###end article-title 120
###begin article-title 121
Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner
###end article-title 121
###begin article-title 122
Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system
###end article-title 122
###begin article-title 123
Cyclophilin D as a drug target
###end article-title 123
###begin article-title 124
Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease
###end article-title 124
###begin article-title 125
Overview of cell death signaling pathways
###end article-title 125
###begin article-title 126
14-3-3 inhibits Bad-induced cell death through interaction with serine-136
###end article-title 126
###begin article-title 127
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis
###end article-title 127
###begin article-title 128
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt
###end article-title 128
###begin article-title 129
Mitochondrial membrane potential and ischemic neuronal death
###end article-title 129
###begin article-title 130
Mitochondrial membrane potential and aging
###end article-title 130
###begin article-title 131
###xml 112 115 <span type="species:ncbi:10116">rat</span>
Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons
###end article-title 131
###begin article-title 132
###xml 0 22 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 46 51 <span type="species:ncbi:9606">human</span>
Pseudomonas aeruginosa triggered apoptosis of human epithelial cells depends on the temperature during infection
###end article-title 132
###begin article-title 133
Bioenergetics and the formation of mitochondrial reactive oxygen species
###end article-title 133
###begin article-title 134
Mitochondrial H(+) leak and ROS generation: an odd couple
###end article-title 134
###begin article-title 135
Adaptive thermogenesis: orchestrating mitochondrial biogenesis
###end article-title 135
###begin article-title 136
Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator
###end article-title 136
###begin article-title 137
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
###end article-title 137
###begin article-title 138
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
###end article-title 138
###begin article-title 139
Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor
###end article-title 139
###begin article-title 140
Metabolic control through the PGC-1 family of transcription coactivators
###end article-title 140
###begin article-title 141
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice
###end article-title 141
###begin article-title 142
PGC-1beta in the regulation of hepatic glucose and energy metabolism
###end article-title 142
###begin article-title 143
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model
###end article-title 143
###begin article-title 144
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein
###end article-title 144
###begin article-title 145
###xml 85 90 <span type="species:ncbi:9606">human</span>
Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece
###end article-title 145
###begin article-title 146
Mitochondrial localization of glucocortocoid receptor in glial (Muller) cells in the salamander retina
###end article-title 146
###begin article-title 147
Steroid and thyroid hormone receptors in mitochondria
###end article-title 147
###begin article-title 148
###xml 43 46 <span type="species:ncbi:10116">rat</span>
Import of the glucocorticoid receptor into rat liver mitochondria in vivo and in vitro
###end article-title 148
###begin article-title 149
The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation
###end article-title 149
###begin article-title 150
Study of subcellular localization and proteolysis of ataxin-3
###end article-title 150
###begin article-title 151
Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria
###end article-title 151
###begin article-title 152
New perspectives on mitochondrial morphology in cell function
###end article-title 152
###begin article-title 153
Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture
###end article-title 153
###begin article-title 154
The mechanism of action of cyclosporin A and FK506
###end article-title 154
###begin article-title 155
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria
###end article-title 155
###begin article-title 156
###xml 34 38 <span type="species:ncbi:10090">mice</span>
A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase
###end article-title 156
###begin article-title 157
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 176 191 <span type="species:ncbi:10090">transgenic mice</span>
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice
###end article-title 157
###begin article-title 158
###xml 57 69 <span type="species:ncbi:11191">Sendai virus</span>
Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells
###end article-title 158
###begin article-title 159
Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9
###end article-title 159
###begin article-title 160
Coupling of caspase-9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell-type-specific
###end article-title 160
###begin article-title 161
An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12
###end article-title 161
###begin article-title 162
A role for mitochondrial dysfunction in perpetuating radiation-induced genomic instability
###end article-title 162
###begin article-title 163
Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis
###end article-title 163
###begin article-title 164
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
###end article-title 164
###begin article-title 165
A new mathematical model for relative quantification in real-time RT-PCR
###end article-title 165
###begin article-title 166
Subcellular localization of SV2 and other secretory vesicle components in PC12 cells by an efficient method of preembedding EM immunocytochemistry for cell cultures
###end article-title 166
###begin article-title 167
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria
###end article-title 167
###begin article-title 168
A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation
###end article-title 168

